Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Hemodiafiltration (HDF) is traditionally used in chronic dialysis, but its superior hemodynamic tolerance and solute clearance make it a promising option for unstable patients. In our department, we applied HDF as an emergency technique for critical patients who could not tolerate conventional hemodialysis (HD) due to hemodynamic instability or rapid metabolic deterioration. This study aimed to describe our experience and evaluate the clinical and biochemical outcomes.
We retrospectively analyzed twelve consecutive patients treated with emergency HDF in our nephrology unit. The main indications were acute pulmonary edema, severe hyperkalemia, metabolic or lactic acidosis, and uremic symptoms. All patients were considered hemodynamically unstable or at high risk for HD intolerance. Pre- and post-dialysis biochemical values (urea, potassium, pH) were compared using the Wilcoxon test. Clinical tolerance and symptom improvement were assessed for each session.
The mean age was 51.6 ± 18.1 years, with 75% males. Emergency HDF achieved rapid metabolic correction: urea decreased from 2.62 ± 1.09 to 1.59 ± 0.46 g/L (p < 0.001), potassium from 5.66 ± 1.43 to 4.11 ± 0.49 mmol/L (p = 0.001), and pH increased from 7.19 ± 0.19 to 7.38 ± 0.03 (p = 0.003). All sessions were well tolerated, with no major hemodynamic events. Most patients showed prompt clinical improvement, especially in respiratory and hemodynamic stability.
Our findings suggest that emergency HDF is a safe and effective option for critical or hemodynamically unstable patients who cannot tolerate conventional HD. It allows rapid metabolic correction with excellent tolerance, making it a valuable alternative in acute care nephrology.